John Stone, MD, MPH, is the world leader in the field of IgG4-related disease research. In this episode, he breaks down the histology of IgG4-related disease, important aspects of what is known about the pathophysiology of the disease, as well as future directions in treatment.

Intro :10
Inside this episode :13
IgG4-related disease background :31
An anecdote 1:15
The interview 4:09
History of IgG4-related disease 4:18
IgG4 pathology and terms 7:48
What makes IgG4 different from other IgG subclasses? 10:23
What do we know about the interplay between B and T cells? 12:31
What is SLAMF7? 16:30
What happens to T cells during B-cell depletion? 18:22
Antigens involved in IgG4 21:06
Future of treatment 23:10
Thank you, Dr. Stone 24:32

We’d love to hear from you! Send your comments/questions to rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum

John Stone, MD, MPH, is director of clinical rheumatology at Massachusetts General Hospital.

IgG4-related Disease with John Stone, MD